{
    "abstract": "Background: Current US mental disorder prevalence estimates have limited usefulness for service planning and are often discrepant. Data on clinical significance from the National Institute of Mental Health Epi- demiologic Catchment Area Program (ECA) and the",
    "reduced_content": "Revised Prevalence Estimates of Mental Disorders\nin the United States\n \n \nBackground: Current US mental disorder prevalence\nestimates have limited usefulness for service planning\nand are often discrepant. Data on clinical significance\nfrom the National Institute of Mental Health Epi-\ndemiologic Catchment Area Program (ECA) and the\nNational Comorbidity Survey (NCS) were used to pro-\nduce revised estimates, for more accurate projections\nof treatment need and further explication of rate dis-\ncrepancies.\nMethods: To ascertain the prevalence of clinically sig-\nnificant mental disorders in each survey, responses to\nquestions on life interference from, telling a profes-\nsional about, or using medication for symptoms were ap-\nplied to cases meeting symptom criteria in the ECA\nlence estimate was made by selecting the lower estimate\nof the 2 surveys for each diagnostic category, account-\ning for comorbidity, and combining categories.\nResults: Using data on clinical significance lowered the\npast-year prevalence rates of \"any disorder\" among 18-\nFor adults older than 18 years, the revised estimate for\nany disorder was 18.5%. Using the clinical significance\ncriterion reduced disparities between estimates in the 2\nsurveys. Validity of the criterion was supported by asso-\nciations with disabilities and suicidal behavior.\nConclusions: Establishing the clinical significance of dis-\norders in the community is crucial for estimating treat-\nment need. More work should be done in defining and\noperationalizing clinical significance, and characteriz-\ning the utility of clinically significant symptoms in de-\ntermining treatment need even when some criteria of the\ndisorder are not met. Discrepancies in ECA and NCS re-\nsults are largely due to methodologic differences.\nAMONG THE issues facing the\nfield of psychiatric epide-\nmiology are 2 challenges\nfor future research. The\nfirst relates to limitations\nin currently available surveys as tools for\nmental health service planning. Two large\ncommunity surveys, the National Insti-\ntute of Mental Health Epidemiologic\nCatchment Area Program (ECA) and the\nNational Comorbidity Survey (NCS), have\nbeen the main sources for estimates of\ntreatment need in the United States.1-3\nThese surveys showed overall 1-year men-\ntal and addictive disorder prevalence rates\napproaching 30% and lifetime rates ap-\nproaching 50%. If these prevalence rates\nare taken as a proxy for mental health treat-\nment need, the mental health system\nwould have to expand enormously to meet\nthis need, with attendant increases in\nworkforce deployment and overall costs.\nAlternatively, the clinical significance of\nthese community-based rates, and there-\nfore their suitability as a proxy for treat-\nment need, has been questioned.4,5 The\nhigh disorder rates in the ECA and NCS\nwere accompanied by low service use rates,\nwith less than one third of persons with\nan active mental disorder using mental\nhealth services in a 1-year period.6,7 The\nextent to which the untreated cases rep-\nresent unmet need for treatment as op-\nposed to absence of need for treatment\nbecause of mild or transient symptoms is\nnot clear.8-11 A closer examination of the\nclinical significance of community preva-\nlence rates is warranted.\nThe second challenge is methodo-\nlogic, having to do with explaining the\ndifferences in the prevalence rates of\nindividual disorders between the ECA\nand the NCS. Reconciling these differ-\nences is important for policy and plan-\nning purposes, in that more consistent\nresults will lead to less confusion among\nthe end users of the data and more\nFrom the American Psychiatric\nInstitute for Research and\nEducation, Washington, DC\n(Drs Narrow and Regier and\nMr Rae); and Department of\nPsychiatry, Washington\nUniversity School of Medicine,\nSt Louis, Mo (Dr Robins).\n\u00a92002 American Medical Association. All rights reserved.\nconfidence in the reliability of the methods and the\ndiagnoses themselves. Recent work4 showed that the\ndifferences could be partially reconciled by accounting\nfor changes in diagnostic criteria between DSM-III and\nDSM-III-R (particularly for the anxiety disorders), and\nthe different age ranges in the 2 surveys. Several factors\ncould not be controlled for, including different sam-\npling frames, the use of a \"commitment question\" in\nthe NCS, and stem question placement and other differ-\nences (eg, a more complete assessment of phobias) in\nthe NCS diagnostic interview. Another factor that has\nbeen raised but not empirically examined is whether\nthe cases identified by these different survey methods\ndiffer in the clinical significance of their symptoms.\nThat is, do higher rates indicate an improved sensitivity\nof the methods and instrumentation to identify clini-\ncally significant cases, or an oversensitivity, in that the\nexcess cases meet symptom criteria but are not clini-\ncally significant?\nThe concept of clinical significance of mental dis-\norders plays a role in both of these issues. Clinical sig-\nnificance has been a part of the DSM definition of men-\nMETHODS\nThe National Institute of Mental Health ECA has been\ndescribed at length in previous publications.1,2,18 It was\nyears and older. Two face-to-face interviews were done 12\nmonths apart (wave 1 and wave 2). A telephone interview\n(face-to-face in New Haven, Conn) of the household\nrespondents was conducted 6 months after wave 1. Ques-\ntions on use of health services were asked at each inter-\nview. Diagnostic data were obtained at waves 1 and 2\nonly. The data were weighted to account for unequal\nprobabilities of selection for each person sampled and for\nnonresponse. The data were also weighted on the basis of\nthe age, sex, and race or ethnicity distribution of the 1990\nUS Census. The DSM-III psychiatric diagnoses were\nassessed with the DIS.\nThe NCS3 was a cross-sectional survey of a nation-\nally representative household sample of 8098 adoles-\ncents and adults aged 15 to 54 years, conducted from\nsponse and unequal probabilities of selection, and to\nadjust the data to national population distributions on\nthe basis of the 1989 US National Health Interview Sur-\nvey. The UM-CIDI was used to obtain DSM-III-R diag-\nnoses. Although generalized anxiety disorder and post-\ntraumatic stress disorder were assessed only in the NCS,\nobsessive-compulsive disorder, anorexia nervosa, somati-\nzation disorder, and cognitive impairment were assessed\nonly in the ECA.\nIn the ECA DIS, the clinical significance questions were\nas follows: Did you tell a doctor about (symptom[s])? Did\nyou tell any other professional about (symptom[s])?\nDid you take medicine for (symptom[s]) more than once?\nDid (symptom[s]) interfere with your life or activities a lot?\nThe NCS included the following clinical significance ques-\ntions: Did you ever tell a doctor other than a psychiatrist\nabout (symptom[s])? Did you ever see a mental health spe-\ncialist about your (symptom[s])? Did you ever see any other\nprofessional about (symptom[s])? Did you ever take medi-\ncation more than once because of (symptom[s])? How much\ndid your (symptom[s]) ever interfere with your life or ac-\ntivities--a lot, some, a little, or not at all?\nAlthough the questions assessing clinical signifi-\ncance were similar in the 2 studies, they were applied\ndifferently. In the DIS, for anxiety disorders, dysthymia,\nschizophrenia, somatization disorder, anorexia nervosa,\nand antisocial personality disorder, the clinical signifi-\ncance of a symptom was determined by using a decision\ntree of clinical significance questions posed to the\nrespondent. When the respondent acknowledged talking\nto a physician or other professional, or taking medicine,\nor that the symptom interfered with his or her life a lot,\nthen the symptom was treated as clinically significant.\nFor these disorders, the diagnostic algorithms were con-\nstructed so that only clinically significant symptoms\nwere considered. For ECA diagnoses of major depres-\nsion, mania, and drug use disorders, and for virtually all\nof the NCS diagnoses, individual symptoms were not\nassessed for clinical significance. Rather, at the end of\neach diagnostic module, clinical significance questions\nwere posed to those respondents who had sufficient\nsymptoms for a potential diagnosis. The results of these\nquestions could then be applied, independently of the\ndiagnostic algorithm, to the persons who met symptom\ncriteria for a disorder.\nService use during a 1-year period for mental health or sub-\nstance use problems was assessed. For the ECA, treatment\ndata came from the initial interview, or from the 6-month\nand 12-month follow-up interviews, depending on when\nthe respondent's mental disorder was detected.6 For the NCS,\na retrospective report of treatment during the year before\nthe interview was used. Ambulatory settings were catego-\nrized into specialty mental and addictive or general medi-\ncal sectors. Combined, these 2 sectors are referred to as the\nhealth systems sector.6\nTo provide a test of the validity of the clinically signifi-\ncant mental disorders, several variables indicative of\nclinical severity and disability were chosen. From both\nsurveys, lifetime history of suicidal ideation and suicide\nattempts, and whether the respondent was in full-time\nwork or school, were used. From the NCS only, an item\nwas used that inquired whether in the past month the\nrespondent had been unable to work or had had to cut\nback on work or usual activities for 2 or more days.\nFrom the ECA only, receipt of disability compensation\nwas used.\n\u00a92002 American Medical Association. All rights reserved.\ntal disorder starting with DSM-III.12 Currently, DSM-\nIV13 defines a mental disorder as\na clinically significant behavioral or psychological syndrome\nor pattern that occurs in an individual and that is associated\nwith present distress (e.g., a painful symptom) or disability (i.e.,\nimpairment in one or more important areas of functioning) or\nwith a significantly increased risk of suffering death, pain, dis-\nability, or an important loss of freedom.13(pxxi)\nThe concept was further highlighted in DSM-IV by its\ninclusion in the diagnostic criteria for many disorders,\nin the context of distress or impairment in social, occu-\npational, or other important areas of functioning.13(p7)\nFor example, criterion E of generalized anxiety disorder\nstates: \"The anxiety, worry, or physical symptoms cause\nclinically significant distress or impairment in social,\noccupational, or other important areas of function-\nDespite the prominence of clinical significance in\ndiagnostic criteria, there is currently no consensus as to\nhow it should be defined or operationalized. In large\nepidemiologic surveys, direct clinical judgment is rarely\nTo maximize comparability, comparisons between the ECA\nand NCS were limited to the population aged 18 to 54 years.\nAs in previous analyses, we focused on 1-year prevalence and\nused the single wave of data from the NCS and 2 waves of\ndata from the ECA to maximize case ascertainment.4 Preva-\nlence rates of clinically significant disorders were deter-\nmined by identifying the percentage of the population that\nmet all criteria for diagnosis, including clinical significance.\nThe ECA disorders with symptom-level assessment of clini-\ncal significance did not need revisions. To determine rates\nof clinically significant disorders when questions were asked\nfor the syndrome as a whole, rather than symptom by symp-\ntom, we considered a positive response to any of the ques-\ntions (for the NCS life interference question, \"a lot\") to in-\ndicate a clinically significant syndrome. Standard errors were\ncalculated by Taylor series linearization19 and 95% confi-\ndence intervals were constructed. Table 1 summarizes the\nrevisions to the diagnostic variables that were necessary for\nlimiting cases to those with clinical significance.\nBecause no diagnostic algorithm was available for bi-\npolar II disorder in the NCS, it was constructed de novo. We\nalso created a past-year prevalence rate for the ECA's diag-\nnosis of dysthymia. This rate is likely to be an overestimate,\nsince persons with lifetime histories of both major depres-\nsion and dysthymia were asked in the ECA to date only their\nmost recent depressive \"spell,\" whether it was due to dys-\nthymia or major depression.\nTo approximate nontransient conditions of cognitive\nimpairment in the ECA, such as dementia and mental re-\ntardation, respondents were selected who met criteria for\n\"definite\" or \"possible\" severe cognitive impairment at both\nwaves of interviews. Assuming that proxy interviews were\ndue to cognitive impairment in the respondent, persons with\ndefinite or possible severe cognitive impairment at wave 1\nand a proxy interview at wave 2 were also chosen.\nFor DSM-III alcohol abuse, impairment in function-\ning was a required criterion. The DIS assessed this through\nquestions about school or job problems, arrests, family ob-\njections to drinking, and other social problems. The stan-\ndard clinical significance questions were not asked. For al-\ncohol dependence, DSM-III criterion A required either\npathological use or impairment in functioning. To esti-\nmate a clinically significant rate of alcohol dependence in\nthe ECA, impairment in functioning was required whether\nor not there was a pattern of pathological use.\nIn the NCS, previously published rates of substance use\ndisorders were based on \"broad\" definitions of disorder. For\nthe clinically significant rates of substance abuse and depen-\ndence, the \"narrow\" definitions of disorder were used. The\nnarrowabusedefinitionrequiredmeetingabusecriteriawithin\nthe past year and having no history of substance depen-\ndence. The narrow dependence definition required ever hav-\ning had a substance dependence disorder, having had symp-\ntoms in the past 12 months, and having had 3 or more\nsubstance-related problems during the past year. Clinical sig-\nnificance questions were asked in the NCS for both alcohol\nand other drug use disorders. For these analyses, questions\nwere also taken from the UM-CIDI that most closely corre-\nsponded to the alcohol-related impairment questions in the\nDIS. If any one of the clinical significance or other impair-\nment questions was answered positively for the narrowly de-\nfined substance use disorders, then the clinical significance\ncriterion was met.\nToobtainrevisedprevalenceratesforages18to54years,we\nfollowed a conservative procedure previously used in an in-\ndependentscientificanalysiscomparingtheECAandNCS.20\nForthesupraordinatecategoriesofanyanxietydisorder,any\nmood disorder, and any substance use disorder, and for in-\ndividualmiscellaneousdisorders,weselectedthelowerpreva-\nlenceestimateofthe2surveys.Fordisorderscoveredinonly\n1 survey, we used that estimate. To obtain the overall preva-\nlencesfor\"anymentaldisorder\"withandwithoutsubstance\nusedisorders,wecombinedthechosenestimatesafterremov-\ning overlaps to account for comorbidity.\nTo obtain revised prevalence rates for persons 55 years\nor older, a group not interviewed in the NCS, rates in the\nECA were accepted if ECA rates for ages 18 to 54 years were\nlower than NCS rates for that age group. If the NCS had\nthe lower rate, the NCS rate that would have been ob-\ntained for the older age group was estimated by multiply-\ning the NCS rate for the younger group by the ratio be-\ntween estimates for younger and older subjects in the ECA.\nFinally, to obtain prevalence rates for all adults older than\n18 years, the revised estimates for the older and younger\nage groups were weighted by the resident population cen-\nDifferencesinserviceuseandvalidityindicatorsbetween\nrespondentswhometbothdiagnosticandclinicalsignificance\ncriteria and those who met diagnostic criteria without clini-\ncal significance were determined for each supraordinate di-\nagnosticcategory.Becausedysthymiahadsymptom-levelclini-\ncal significance questions in the ECA, the \"diagnosis only\"\ngroup could not be calculated for total mood disorders. In-\nstead,comparisonsforunipolarmajordepressionweremade.\n\u00a92002 American Medical Association. All rights reserved.\nused because of the high cost of clinical time and the\nlarge number of subjects, so proxy measures are\nused.14 The developers of the Diagnostic Interview\nSchedule (DIS) used in the ECA, and the related Uni-\nversity of Michigan version of the Composite Interna-\ntional Diagnostic Interview (UM-CIDI) used in the\nNCS, placed structured questions in the interviews to\naddress the clinical significance of symptoms and\nsyndromes.15-17 With these questions, clinical signifi-\ncance was assumed if the respondent's symptoms led\nhim or her to mention them to a doctor or other pro-\nfessional, or if the symptoms interfered with his or her\neveryday life, or if the respondent took medication for\nthe symptoms. Thus, clinical significance was related,\nif imperfectly, to concepts of symptom prominence or\nseverity (and possibly the resulting distress), impair-\nment in functioning, and treatment (including self-\ntreatment) with medication.\nThe question arises, then, as to whether these ques-\ntions, if applied to the existing prevalence estimates, will\nproduce more realistic rates for policy and service plan-\nning, and to what extent differences in clinical signifi-\ncance affect prevalence differences between the ECA and\nthe NCS. This article presents revised prevalence esti-\nmates of clinically significant mental disorders, with evi-\ndence of their validity, as an initial attempt to address\nthese questions.\nRESULTS\nIn both the ECA and the NCS, prevalence rates were re-\nduced when the available clinical significance questions\nwere applied. For the NCS, these reductions were gen-\nerally in the 30% to 40% range (Table 2). The largest\nchange in NCS prevalence was 50% for social phobia\n(7.4% without the clinical significance questions and 3.7%\nwith the questions), and the smallest change was 18%\nfor generalized anxiety disorder (3.4% without the clini-\ncal significance questions and 2.8% with the questions).\nOverall prevalence rates for NCS \"any mental disorder\"\nand \"any disorder including substance use disorders\" were\nreduced by about one third when the clinical signifi-\ncance questions were applied.\nChanges to the ECA prevalence rates (Table 3)\nwere less striking than in the NCS, because for rela-\ntively few disorders in the ECA was symptom informa-\ntion collected independent of the clinical significance\nquestions. For example, there was no change in the\nprevalence of anxiety disorders from previously pub-\nlished rates because only clinically significant symp-\ntoms were included in the diagnostic algorithms. In\ncontrast, the prevalence of ECA unipolar major depres-\nTable 1. Overview of Methods to Produce Rates of Clinically Significant Disorders*\nSimple phobia NC CS: syndrome\nSocial phobia NC CS: syndrome\nAgoraphobia NC CS: syndrome\nGeneralized anxiety disorder . . . CS: syndrome\nPanic disorder NC CS: syndrome\nObsessive-compulsive disorder NC . . .\nPosttraumatic stress disorder . . . CS unavailable\nMDE; unipolar major\ndepression\nCS: syndrome CS: syndrome; removed episodes with duration 2 wk\nDysthymia NC; new 1-y rate calculated CS: syndrome\nBipolar I CS: syndrome NC\nBipolar II CS: syndrome, from mania and MDE modules CS: syndrome; new diagnostic algorithm\nSchizophrenia NC; DSM-III criterion C applied See nonaffective psychosis\nNonaffective psychosis . . . NC; results from clinical interviews were used\nSomatization NC . . .\nAntisocial personality disorder NC No 1-y rates\nAnorexia nervosa NC . . .\nSevere cognitive impairment Definite/possible SCI at wave 1, with definite/\npossible SCI or proxy interview at wave 2\n. . .\nAlcohol abuse NC NCS narrow definition of abuse; CS: syndrome; other impairment\nquestions applied\nAlcohol dependence Impairment questions from abuse diagnosis NCS narrow definition of dependence; CS: syndrome; other\nimpairment questions applied: syndrome level\nDrug abuse CS: syndrome NCS narrow definition of abuse; CS: syndrome; other impairment\nquestions applied: syndrome level\nDrug dependence CS: syndrome NCS narrow definition of dependence; CS: syndrome; other\nimpairment questions applied: syndrome level\n*ECA indicates Epidemiologic Catchment Area Program; NCS, National Comorbidity Survey; NC, no changes were needed for clinical significance; CS: syndrome,\nclinical significance questions were applied at the syndrome level; CS unavailable, clinical significance questions were unavailable for diagnosis; MDE, major depressive\nepisode; SCI, severe cognitive impairment; and ellipses, diagnosis unavailable.\nDetailed methods available from one of us (W.E.N.).\n\u00a92002 American Medical Association. All rights reserved.\nsion, for which clinical significance was asked at the\nsyndrome level, was reduced by 23% when clinical sig-\nnificance questions were used, compared with a 39%\ndecrease in the NCS. Severe cognitive impairment and\ndrug use disorders among 18- to 54-year-olds in the\nECA showed large decreases in prevalence when clini-\ncal significance data were applied. Table 3 also shows\nthat the previous usage of a lifetime estimate of dysthy-\nmia without the clinical significance criterion grossly\ninflated the previously published 1-year estimates for\nany mood disorder in the ECA. The large reduction in\ndysthymia prevalence contributed to a 44% reduction\nin the rate of any mood disorder with clinical signifi-\ncance compared with previously published rates. Over-\nall, the ECA prevalence rates for any disorder and any\ndisorder including substance use disorders were\nIn the group aged 55 years and older in the ECA,\nrates for mental disorders were generally lower than in\nthe 18- to 54-year-old group, particularly for substance\nuse disorders, panic disorder, and antisocial personality\ndisorder. As expected, rates were higher for severe cog-\nnitive impairment in this age group. Overall, 15.2% of\npersons older than 54 years had a clinically significant\nmental disorder, and 17.3% had either a mental or sub-\nstance use disorder. When age groups were combined\nin the ECA, 17.2% of the adult population had a mental\ndisorder, and 22.5% had a mental or substance use dis-\norder.\nComparisons between the 2 surveys are not straightfor-\nward because of their different methods for assessing\nclinical significance. However, the 95% confidence\nintervals in Tables 2 and 3 show that, after the clinical\nsignificance criterion is applied, the NCS rates are usu-\nally the same or lower than the comparable ECA rates.\nThe exceptions to this are social phobia, which had a\nsignificant change in criteria between DSM-III and\nDSM-III-R and was assessed in a different manner in the\nNCS, and bipolar disorder. Notably, differences in\nmajor depression rates are not statistically significant\nafter the clinical significance criterion is applied,\nalthough the ECA point estimates remain lower than\nthose of the NCS.\nTable 4 shows the revised estimates of clinically sig-\nnificant mental disorders. With the use of the conserva-\ntive method of accepting the figure from the survey with\nthe lower prevalence estimate when both surveys cov-\nered the disorder, the NCS was chosen for the supraor-\ndinate anxiety and substance use disorders categories, and\nthe ECA was chosen for mood disorders. When only 1\nsurvey covered the disorder, its estimate was used, so gen-\neralized anxiety disorder and posttraumatic stress dis-\norder were taken from the NCS; obsessive-compulsive\ndisorder, antisocial personality disorder, anorexia ner-\nvosa, somatization disorder, and severe cognitive im-\npairment were taken from the ECA. For schizophrenia\u00ad\nnonaffective psychosis, we used the ECA estimate because\nthe NCS's unique clinical reassessment method was\napplied to no other disorder in either survey. After ac-\ncounting for comorbidity and combining the chosen es-\ntimates, the overall revised 1-year prevalence rate for 18-\nto 54-year-olds was 16.5% for any mental disorder not\nincluding substance use disorders and 20.9% for any men-\ntal or substance use disorder (Table 4). For all persons\nolder than 18 years, the overall prevalence of any men-\ntal or substance use disorder was 18.5%, reflecting the\nlower prevalence of disorders in persons older than 54\nyears.\nThe percentage of persons with a clinically significant\nmental or addictive disorder who used services in the\nhealth systems sector was remarkably similar for the ECA\nTable 2. One-Year Prevalence Rates From the NCS Study*\nBefore Clinical\nSignificance\nCriteria\nWith Clinical\nSignificance\nCriteria\nPosttraumatic stress\ndisorder\nAny disorder including\nsubstance use\nconfidence intervals in parentheses. NCS indicates National Comorbidity\nSurvey.\nIn the University of Michigan version of the Composite International\nDiagnostic Interview, no clinical significance questions were included in the\nposttraumatic stress disorder module. Rates without clinical significance were\nused in the \"with clinical significance\" column for any anxiety disorder, any\ndisorder, and any disorder including substance use.\nBipolar I disorder, bipolar II disorder, nonaffective psychosis, and lifetime\nantisocial personality disorder were included in the \"before clinical significance\"\ncolumn for any mood disorder, any disorder, and any disorder including\nsubstance use, to facilitate comparisons with previously published estimates.\n\u00a7Bipolar I rate is from the Composite International Diagnostic Interview\nalgorithm rather than clinical reappraisal. Clinical reappraisal rate was\n\u00a92002 American Medical Association. All rights reserved.\nand the NCS (Table 5). With the clinical significance\ncriterion in place, the ECA showed slightly higher over-\nall rates of use in the general medical sector and lower\nrates of use in the specialty mental and addictive sector\ncompared with the NCS. The major disparity in overall\nuse between the 2 surveys was among persons with mood\ndisorders because of differences in general medical use.\nCompared with previous analyses of the 2 surveys that\ndid not use the clinical significance questions,6,7 service\nuse rates increased more for the NCS disorders than for\nthe ECA disorders when clinical significance was re-\nquired. As expected given the nature of the clinical sig-\nnificance questions, reported ambulatory service use was\nsignificantly lower for those who met symptom criteria\nwithout meeting the clinical significance criterion than\nfor those who met the clinical significance criterion.\nThe usefulness of the clinical significance indicators was\nevaluated by their association with suicidal ideas and be-\nhavior and indicators of disability (Table 6). Higher lev-\nels of suicidal ideation and attempts were associated with\nclinically significant disorders in both surveys for anxi-\nety disorders and unipolar major depression, but not for\nsubstance use disorders. Indicators of disability (ie, re-\nceiving disability compensation and problems with work\nin the past month) showed similar trends for anxiety\ndisorders and substance use disorders in the NCS.\nComorbidity between clinically significant and non\u00ad\nclinically significant disorders may have obscured dif-\nferences in the validity comparisons. For example, fur-\nther analyses showed that half the persons in the NCS\nwhose substance use disorder did not meet the clinical\nsignificance criterion had another disorder that was clini-\ncally significant. In both surveys about one third of those\nwith a disorder that did not meet the clinical signifi-\ncance criterion had a comorbid disorder that did.\nCOMMENT\nThe prevalence rates of mental and substance use disor-\nders were substantially reduced by using data generated\nfrom the ECA and NCS clinical significance questions.\nThese revised rates represented a group of persons with\nhigher levels of disability and suicidal ideation than in\nprevious estimates, which we consider preliminary evi-\ndence of the validity of the data. We also found a high\ndegree of comorbidity between clinically significant and\nnon\u00adclinically significant syndromes. Discrepancies in\nthe rates of mood disorders between the ECA and the NCS,\na source of scientific controversy in the past, were brought\nTable 3. One-Year Prevalence Rates From the ECA Study*\nBefore Clinical Significance Criteria With Clinical Significance Criteria\nAll Ages\nAll Ages\nAny disorder including\nsubstance use\n*Data are percentages with 95% confidence intervals in parentheses. ECA indicates Epidemiologic Catchment Area Program.\nFor anxiety disorders, anorexia nervosa, and somatization disorder in the ECA, clinical significance was assessed at the symptom level, so rates without clinical\nsignificance could not be determined. In the \"before clinical significance\" columns, rates for those disorders with clinical significance are included in italics, and are also\nincluded in the rates of \"any disorder\" and \"any disorder including substance use,\" to facilitate comparisons with previously published estimates (Regier et al6).\nFor dysthymia, clinical significance was assessed at the symptom level, so rates without clinical significance could not be determined. The rates presented in the\n\"before clinical significance\" columns are lifetime rates, to facilitate comparisons with previously published estimates (Regier et al6).\n\u00a92002 American Medical Association. All rights reserved.\nsignificantly closer together with use of the clinical sig-\nnificance data.\nThese analyses raise several methodologic issues. Al-\nthoughwefoundsignificantdifferencesbetweenthosewho\nmet and did not meet clinical significance criteria as op-\nerationalized by the developers of the DIS and the CIDI,\nassessment methods need further study. For example, is it\npreferabletoassessclinicalsignificanceatthesymptomlevel,\naswiththeECAanxietydisorders,oratthesyndromelevel,\nas with the ECA and NCS mood disorders? Furthermore,\nit is not yet clear whether survey questions assessing clini-\ncal significance should be uniform across disorders, as in\nthe ECA and NCS, or tailored to distinctive clinical char-\nacteristics and impairments of individual disorders. For ex-\nample, the degree and quality of life interference experi-\nenced by persons with drug dependence will likely differ\non aggregate from the life interference experienced by per-\nsons with social phobia. Such differences are not picked\nup by the current clinical significance questions. The use-\nfulness of global assessments of functioning and their re-\nlationships to disorder-level assessments also need fur-\nther clarification.21\nThe ongoing experience of comparing and recon-\nciling the 2 surveys points out the importance of having\nexplicit criteria for all aspects of mental disorders, in-\ncluding clinical significance, functional impairment, and\nsubjective distress. This methodologic work also points\nout the complexity of community surveys of mental dis-\norders and the large effects that seemingly small modi-\nfications can have on their results. It is not until these\nchanges are understood that we can have a good idea\nwhether rate differences are real or methodologic arti-\nfacts. It now appears that many of the differences in ECA\nand NCS rates are due to differences in methods.\nThe policy implications of epidemiologic survey re-\nsults continue to resonate as mental health systems, both\npublicandprivate,struggletocompeteforshrinkinghealth\ncare dollars. Even relatively modest changes in the preva-\nlence rate of mental disorders will have an impact on the\nplanning of service systems. For example, in this study the\nchange in overall prevalence of mental disorders from\nthe use of our conservative point estimates represents a\ncans, respectively. For all adults older than 18 years, the\nrevised estimate of 18.5% represents a decrease of about\ngood news is that these lower numbers are likely to rep-\nresent a group more needful of services. Unfortunately,\neven when disorders are restricted to those with clinical\nsignificance,theirnumbersarestilloverwhelmingforplan-\nning purposes. There are several unremediable sources of\nimprecision in our current data, which, if remedied, might\nhaveproducedfurtherreductionsinprevalencerates.These\ninclude the lifetime time frame of the DIS and UM-CIDI,\nwhichdoesnotallowforassessmentofthepresenceofeach\nsymptom in the past year. Similarly, the clinical signifi-\ncance questions were asked only on a lifetime basis. In-\ncorporating more specific dating of this information would\nprobably reduce the prevalence rates, although at the ex-\npenseofincreasedrespondentburden.Theimperfectspeci-\nficity of the diagnostic instruments likely also contrib-\nutes to overestimates of true prevalence rates. Finally, the\nclinical significance question about life and activity inter-\nference was different in the 2 surveys. The ECA used a di-\nchotomous response option (yes [a lot] or no [not a lot])\nand the NCS used a scaled response (\"a lot,\" \"some,\" \"a\nlittle,\" or \"not at all\"). Persons who answered yes to the\nECA question may have answered \"some\" if the NCS ques-\ntion had been used, and therefore would not have met the\nclinical significance criterion as we defined it.\nAs psychiatric epidemiology moves into its next gen-\neration, a major goal will therefore be to establish more\nTable 4. Revised One-Year Prevalence Rates,\nAged 18 Years and Older*\nAged\n%\nAged\n%\nAll Ages,\n%\nPopulation,\nMillions\nGeneralized anxiety\ndisorder\nObsessive-compulsive\ndisorder\u00a7\nPosttraumatic stress\ndisorder\nMajor depressive\nepisode\u00a7\nUnipolar major\ndepression\u00a7\nSchizophrenia/\nschizophreniform\u00a7\nAntisocial personality\ndisorder\u00a7\nSevere cognitive\nimpairment\u00a7\nAny substance use\ndisorder\nAny alcohol use\ndisorder\nAny other drug use\ndisorder\nAny mental or substance\nuse disorder\n*NA indicates rates not available in Epidemiologic Catchment Area Program\n(ECA) or National Comorbidity Survey (NCS); ellipses, not applicable.\nPopulation estimates are based on July 1, 1999, US census estimate of\ndisorder and posttraumatic stress disorder, because of lack of data for\npopulation older than 54 years, population estimates are based on July 1, 1999,\nThe NCS DSM-III-R disorders.\n\u00a7The ECA DSM-III disorders.\nThe ECA rate for obsessive-compulsive disorder not comorbid with another\nanxiety disorder is 1.2%.\n\u00a92002 American Medical Association. All rights reserved.\nprecise and clinically relevant prevalence estimates than\ndid the ECA and the NCS, the seminal surveys of this\ngeneration. Several challenges lie ahead. First, the field\nhas progressed to a point where large, expensive \"catch-\nall\" surveys will be replaced by surveys targeted to spe-\ncific goals. Unmet treatment need is sure to be one goal;\ncausal and protective factors are sure to be another, but\nthe ideal design for one goal is not the same as that for\nthe other. Second, efforts to improve the validity of the\nDIS and CIDI disorders should continue. Third, ad-\nvances in the operationalization of disability constructs\nand their translation into survey instruments should be\nincorporated into research plans. Future population-\nbased surveys should include full assessments of\nfunctioning and link level of functioning to the course\nof mental disorders over time. The development and psy-\nchometric testing of the second World Health Organi-\nzation Disability Assessment Schedule for administra-\ntion by lay interviewers holds promise in this regard.22,23\nFurther work also needs to be done in defining treat-\nment need, beyond current diagnostic notions. Persons\nwith subsyndromal psychiatric symptoms can have\nTable 5. One-Year Disorders With and Without Clinical Significance: Percentage of Persons Receiving Ambulatory Treatment\nin the Past Year for Mental Health or Substance Use Reasons, Aged 18 to 54 Years*\nAny Anxiety\nDisorder Any Mood\nDisorder\n(+CS)\nUnipolar MDD\nAny Substance\nAbuse/Dependence Any Mental\nDisorder\n(+CS)\nAny Disorder\nIncluding\nSubstance\n(+CS)\nECA\nNCS\n*MDD indicates major depressive disorder; -CS, persons who met symptom but not clinical significance criteria; +CS, persons who met both symptom and clinical\nsignificance criteria; ECA, Epidemiologic Catchment Area Program; SMA, specialty mental and addictive disorders service sector; NCS, National Comorbidity Survey; and\nellipses, not applicable. For NCS any anxiety disorder, posttraumatic stress disorder is not included in either -CS or +CS category. P values are for Wald 2 comparing\n+CS and -CS for any anxiety disorder, unipolar major depressive disorder, and any substance abuse/dependence.\nTable 6. One-Year Disorders With and Without Clinical Significance: Percentage of Persons With Specified\nValidity Indicators, Aged 18 to 54 Years*\nAny Anxiety\nDisorder\nUnipolar Major\nDepression\nAny Substance\nAbuse/Dependence\nECA\nNCS\nDisability 2 d in past month\n*-CS indicates persons who met symptom but not clinical significance criteria; +CS, persons who met both symptom and clinical significance criteria; ECA,\nEpidemiologic Catchment Area Program; NCS, National Comorbidity Survey; and ellipses, not applicable. For NCS any anxiety disorder, posttraumatic stress disorder is\nnot included in either -CS or +CS category. P values are for Wald 2 comparing -CS and +CS for any anxiety disorder, unipolar major depression, and any substance\nabuse/dependence.\n\u00a92002 American Medical Association. All rights reserved.\nsignificant disability and therefore may require treat-\nment.24-26 These subsyndromal cases represent persons\nwho may never meet disorder criteria, who may be in the\nprodromal phase of a full-blown mental disorder, or who,\nbecause of treatment or spontaneous remission, no longer\nmeet full criteria for a disorder.27 Longitudinal descrip-\ntive and experimental studies would help clarify this het-\nerogeneous group's characteristics and need for mental\nhealth services. Very little is known about the clinical sig-\nnificance and treatment needs for disorders that are not\ncurrently included in epidemiologic surveys, such as most\npersonality disorders, adjustment disorders, and im-\npulse control disorders. In addition, estimates of treat-\nment refusal by those with clinically significant disor-\nders would be helpful to complete the picture of unmet\nneed. Finally, the lack of any definitive epidemiologic\nstudy of the mental health needs of children in the United\nStates has been a hindrance. Estimates of treatment need\nin this group vary widely, and all are based on limited\nsamples.28 The developmental consequences of childhood-\nonset disorders, including their persistence into adult-\nhood, are necessary to form a clinically and developmen-\ntally sensitive epidemiology of mental disorders.\nThis study was supported with funds from the Ameri-\ncan Psychiatric Foundation, Washington, DC, and the van\nAmeringen Foundation, New York, NY.\nEarlier versions of this article were prepared while the\nfirst author (W.E.N.) was with the National Institute of Men-\ntal Health, Bethesda, Md, and were presented at the An-\nnual Meeting of the American Psychiatric Association, Wash-\nthe World Psychiatric Association Section on Epidemiol-\nogy and Public Health, Turku, Finland, August 3, 1999.\nWe thank Ronald C. Kessler, PhD, Maritza Rubio-\nStipec, ScD, and the peer reviewers of the ARCHIVES for their\nhelpful comments and assistance on previous versions of this\narticle.\nCorrespondingauthorandreprints:WilliamE.Narrow,\nMD, MPH, American Psychiatric Institute for Research and\nwnarrow@psych.org).\nREFERENCES\n1. Robins LN, Regier DA, eds. Psychiatric Disorders in America. New York, NY: Free\n2. Regier DA, Myers JK, Kramer M, Robins LN, Blazer DG, Hough RL, Eaton WW,\nLocke BZ. The NIMH Epidemiologic Catchment Area program: historical con-\ntext, major objectives, and study population characteristics. Arch Gen Psychia-\n3. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen\nHU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric dis-\norders in the United States: results from the National Comorbidity Survey. Arch\n4. Regier DA, Kaelber CT, Rae DS, Farmer ME, Knauper B, Kessler RC, Norquist GS.\nLimitations of diagnostic criteria and assessment instruments for mental disor-\n5. Bebbington P. The need for psychiatric treatment in the general population. In:\nAndrews G, Henderson S, eds. Unmet Need in Psychiatry. Cambridge, England:\n6. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The\nde facto US mental and addictive disorders service system: Epidemiologic Catch-\nment Area prospective 1-year prevalence rates of disorders and services. Arch\n7. Kessler RC, Zhao S, Katz SJ, Kouzis AC, Frank RG, Edlund M, Leaf P. Past-year\nuse of outpatient services for psychiatric problems in the National Comorbidity\n\u00a8n TB, Chatterji S, Rehm J. Limitations of diagnostic paradigm: it doesn't ex-\n9. Spitzer RL. Diagnosis and need for treatment are not the same [commentary].\n10. Pincus HA, Zarin DA, First M. \"Clinical significance\" and DSM-IV. Arch Gen Psy-\n11. Henderson S. Conclusion: the central issues. In: Andrews G, Henderson S, eds.\nUnmet Need in Psychiatry. Cambridge, England: Cambridge University Press; 2000:\n12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental\nDisorders, Third Edition. Washington, DC: American Psychiatric Association;\n13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental\nDisorders, Fourth Edition. Washington, DC: American Psychiatric Association;\n14. Wittchen HU, \u00dcstu\n\u00a8n TB, Kessler RC. Diagnosing mental disorders in the com-\n15. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health\nDiagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen\n16. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablen-\nski A, Pickens R, Regier DA, Sartorius N, Towle LH. The Composite International\nDiagnostic Interview: an epidemiologic instrument suitable for use in conjunc-\ntion with different diagnostic systems and in different cultures. Arch Gen Psy-\n17. Leaf PJ, Myers JK, McEvoy LT. Procedures used in the Epidemiologic Catch-\nment Area Study. In: Robins LN, Regier DA, eds. Psychiatric Disorders in America.\n18. Eaton WW, Kessler LG, eds. Epidemiologic Field Methods in Psychiatry: The NIMH\nEpidemiologic Catchment Area Program. Orlando, Fla: Academic Press Inc; 1985.\n19. Shah BV, Barnwell BG, Hunt PN, LaVange LM. SUDAAN User's Manual, Release\n20. Andrews G. Workforce deployment: reconciling demands and resources. Aust\n21. Bird HR, Davies M, Fisher P, Narrow WE, Jensen PS, Hoven C, Cohen P, Dulcan\nMK. How specific is specific impairment? J Am Acad Child Adolesc Psychiatry.\n22. World Health Organization. ICIDH-2: International Classification of Functioning,\nDisability and Health: Prefinal Draft, Full Version. Geneva, Switzerland: World Health\n23. World Health Organization. Disability Assessment Schedule: WHODAS II: Phase\n2 Field Trials--Health Services Research, 36-Item Interviewer Administered, Day\nCodes Version. Geneva, Switzerland: World Health Organization; 2000.\n24. Horwath E, Johnson J, Klerman GL, Weissman MM. What are the public health\n25. Olfson M, Broadhead WE, Weissman MM, Leon AC, Farber L, Hoven C, Kathol\nR. Subthreshold psychiatric symptoms in a primary care group practice. Arch\n26. Judd LL, Akiskal HS, Paulus MP. The role and clinical significance of subsyn-\ndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect\n27. Narrow WE, Regier DA, Rae DS, Manderscheid RW, Locke BZ. Use of services\nby persons with mental and addictive disorders: findings from the National In-\nstitute of Mental Health Epidemiologic Catchment Area Program. Arch Gen Psy-\n28. Narrow WE, Regier DA, Goodman SH, Rae DS, Roper MT, Bourdon KH, Hoven C,\nMoore R. A comparison of federal definitions of severe mental illness among chil-\n\u00a92002 American Medical Association. All rights reserved."
}